SPARC1613
CLR_16_13
Phase 1 small_molecule completed
Quick answer
SPARC1613 for Recurrent or Metastatic Breast Cancer is a Phase 1 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Advanced Accelerator Applications
- Indication
- Recurrent or Metastatic Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed